Revance Therapeutics Inc (RVNC) Earnings Report - Forecasts and Surprise Ratio

Revance Therapeutics Inc
RVNC
(Nasdaq - US)
Closed
3.72
-0.12 (-3.13%)
in:usd•As of: Nov 22, 2024 15:59 UTC -5
After Market:3.73+0.01 (+0.27%)
Open
3.80
High
3.89
Low
3.69

Quarterly Earnings History

RVNC ratio: 43%

100%

RVNC beat 15 of 35 last estimates

Date of next report: Feb 26, 2025

Estimate for Q4 24: $-0.28

Implied change from Q3 24: -24.32%

Implied change from Q4 23: -54.84%

Earnings Period	Date Reported	EPS / Forecast	Surprise
Q3 24	Nov 7, 2024	$-0.37 / $-0.35	$-0.02 / -5.71%
Q2 24	Aug 8, 2024	$-0.36 / $-0.48	$0.12 / 25%
Q1 24	May 9, 2024	$-0.54 / $-0.66	$0.12 / 18.18%
Q4 23	Feb 28, 2024	$-0.62 / $-0.79	$0.17 / 21.52%
Q3 23	Nov 8, 2023	$-0.74 / $-1.02	$0.28 / 27.45%
Q2 23	Aug 8, 2023	$-0.8 / $-0.72	$-0.08 / -11.11%
Q1 23	May 9, 2023	$-0.74 / $-0.75	$0.01 / 1.33%
Q4 22	Feb 28, 2023	$-1.82 / $-1.04	$-0.78 / -75%

Data Vendor: Xignite Logo